Clinicopathological significance of RCAN2 production in gastric carcinoma
Researchers examined calcineurin 2 (RCAN2) regulators and expression patters, finding RCAN2 is correlated with tumor progression and an independent prognostic... Read More
Our Impact
Gastric Cancer Foundation improves the lives of people affected by gastric (stomach) cancer by supporting patient education initiatives and innovative research studies to improve treatments and ultimately, find a cure.
Support Research for a Cure
Every contribution to Gastric Cancer Foundation makes a difference. Honor a loved one, make a tribute to someone’s memory, honor a happy occasion by making a meaningful donation.
-
Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends
A review of evolving trends in third line treatment of advanced gastric cancer shows sequential treatment approaches benefit a growing... Read More
ENA NEWS: Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug
New research published in European Cancer finds gastric cancer patients respond well to a new anti-HER2 drug, which binds to... Read MoreDr. Iqbal on Second- and Third-Line Therapies in Gastric Cancer
Dr. Syma Iqbal, Keck School of Medicine at University of Southern California, discusses second- and third-line therapies in gastric cancer... Read More
Implications of FGF 2 Amplification for GI Cancer Treatment
Watch this new video on the implications of fibroblast growth factor (FGF) 2 amplification for GI Cancer Treatment.
FDA Grants Priority Review to TAS-102 for Gastric/GEJ Cancer
Shared in OncLive, the FDA has granted priority review to a supplemental new drug application for TAS-102 (trifluridine/tipiracil; Lonsurf) for... Read More
Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis
A meta-analysis investigates the relationship between H. pylori status (H. pylori negative, H. pylori eradication and H. pylori persistence) and... Read More
Women more prone to selected oesophagogastric cancer chemotherapy side-effects
New research presented at ESMO investigates whether men and women should be treated differently in cancer care, finding women are... Read More
Molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer
Published in the Future Science Group, new research projects molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer.-
Taiho Oncology and Servier Announce Positive Results from LONSURF® (trifluridine/tipiracil) Study Presented at ESMO 2018 Congress and Published in The Lancet Oncology
Lonsurf receives FDA priority review for metastatic gastric cancer, with a new study presented at ESMO 2018 Congress and published... Read More 
A Risk-Scoring Model for Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Retrospective Study and External Validation
Scientists test a risk-scoring mode for developing lymph node metastasis that can guide and personalize treatment for patients with early... Read More
Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival
New research shows immunohistochemical classification, the process of detecting antigens (e.x. proteins) in tissue cells, is associated with gender, outcomes,... Read More
Current Challenges in Gastric Cancer Surgery
Published in Elsevier Connect, researchers review recent trends in treating gastric cancer as well as new reconstructive methods improving post-op... Read More
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors
With the liver a common site for gastric cancer recurrence, researchers in Elsevier Connect identified prognostic factors for using hepatectomy... Read More-
Research Links Specific H. Pylori Strain with Stomach Cancer Risk
An interesting study published in PLOS Medicine identifies a specific H. pylori strain associated with gastric cancer risk. 
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
Research in its very early stages uses engineered immune cells (CAR-T) to target gastric cancer tumors.
Eating junk food tied to higher risk of numerous cancers
A new study in PLOS Medicine finds eating unhealthy food is associated with a higher risk of developing cancer, including... Read More
Five Prime Therapeutics Completes Phase 1 Safety Lead-In and Initiates Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers
A new phase 3 trial of Bemarituzumab for patients with advanced gastric cancer is open for enrollment. Curious about clinical... Read More
November is Gastric Cancer Awareness Month
Get ready for November and think about hosting an event or fundraiser. Reach out to family, friends and colleagues and... Read More
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Research published in the American Society of Clinical Oncology shows nivolumab and nivolumab plus ipilimumab has durable response and encouraging long-term... Read More
Monthly Newsletter
We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.